XML 14 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Founders Preferred Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income Loss
Accumulated Deficit
Series A Convertible Preferred Stock
Class A Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Class B Common Stock
Common Stock
Beginning balance (in shares) at Dec. 31, 2019           94,818,151        
Beginning balance at Dec. 31, 2019           $ 244,743        
Ending balance (in shares) at Mar. 31, 2020           94,818,151        
Ending balance at Mar. 31, 2020           $ 244,743        
Beginning balance (in shares) at Dec. 31, 2019   26,206,837                
Beginning balance at Dec. 31, 2019 $ (211,730) $ 3 $ 10,457 $ (1) $ (222,203)     $ 14   $ 0
Beginning balance (in shares) at Dec. 31, 2019               139,635,890   0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Share-based compensation 1,141   1,141              
Other comprehensive Income (7)     (7)            
Net loss (15,581)       (15,581)          
Ending balance (in shares) at Mar. 31, 2020   26,206,837                
Ending balance at Mar. 31, 2020 (226,177) $ 3 11,598 (8) (237,784)     $ 14   $ 0
Ending balance (in shares) at Mar. 31, 2020               139,635,890   0
Beginning balance (in shares) at Dec. 31, 2020           0        
Beginning balance at Dec. 31, 2020           $ 0        
Ending balance (in shares) at Mar. 31, 2021           0        
Ending balance at Mar. 31, 2021           $ 0        
Beginning balance (in shares) at Dec. 31, 2020   0                
Beginning balance at Dec. 31, 2020 148,741 $ 0 733,175 34 (584,501)     $ 22   $ 11
Beginning balance (in shares) at Dec. 31, 2020               218,818,037   105,118,203
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Conversion of SAFE into Series A common stock and Issuance of Class A common stock upon exercise of warrants (in shares)               15,757,955    
Conversion of SAFE into Series A common stock and Issuance of Class A common stock upon exercise of warrants 492,542   492,541         $ 1    
Share-based compensation 1,843   1,843              
Other comprehensive Income (43)     (43)            
Net loss (75,923)       (75,923)          
Ending balance (in shares) at Mar. 31, 2021   0                
Ending balance at Mar. 31, 2021 $ 567,160 $ 0 $ 1,227,559 $ (9) $ (660,424)     $ 23   $ 11
Ending balance (in shares) at Mar. 31, 2021             234,575,992 234,575,992 105,118,203 105,118,203